Serum- and calcium-induced differentiation of human keratinocytes is inhibited by the E6 oncoprotein of human papillomavirus type 16

Journal of Virology

Volumn 70, Issue 5, 1996, Pages 3269-3279

  Sherman, L ^a,b   Schlegel, R ^a  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; EPITOPE; ONCOPROTEIN;

ARTICLE; CELL DIFFERENTIATION; CELL IMMORTALIZATION; CELL PROLIFERATION; CONTROLLED STUDY; GENE MAPPING; HUMAN; HUMAN CELL; KERATINOCYTE; PRIORITY JOURNAL; UTERINE CERVIX DYSPLASIA; WART VIRUS;

EID: 0029968641     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.5.3269-3279.1996     Document Type: Article

References (68)

1. Androphy, E. J., N. L. Hubbert, J. T. Schiller, and D. R. Lowy. 1987. Identification of the HPV-16 E6 protein from transformed mouse cells and human cervical carcinoma cell lines. EMBO J 6:989-992.
2. Baker, C. C., W. C. Phelps, V. Lindgren, M. J. Braun, M. V. Gonda, and P. M. Howley, 1987. Structural and transcriptional analysis of human papillomavirus type 16 sequences in cervical carcinoma cell lines. J. Virol 61: 962-971.
3. Baker, S. J., S. Markowitz, E. R. Fearon, J. K. V. Willson, and B. Vogelstein. 1990. Suppression of human colorectal carcinoma cell line growth by wild type p53. Science 249:1912-1915.
4. Band, V., S. Dalal, L. Delmolino, and E. J. Androphy. 1993 Enhanced degradation of p53 protein in HPV-6 and BPV-1 E6 immortalized human mammary epithelial cells. EMBO J. 12:1847-1852.
5. Band, V., J. A. DeCaprio, L. Delmolino, V. Kulesa, and R. Sager. 1991 Loss of p53 protein m human papillomavirus type 16 E6-immortalized human mammary epithelial cells. J. Virol. 65:6671-6676.
6. Banks, L., and L. Crawford. 1988. Analysis of human papillomavirus type 16 polypeptides in transformed primary cells Virology 165:326-328.
7. Barbosa, M. S., D. R. Lowy, and J. T. Schiller. 1989. Papillomavirus polypeptides E6 and E7 are zinc-binding proteins. J. Virol. 63:1404-1407.
8. Bedell, M. A., K. H. Jones, S. R. Grossman, and L. A. Laimins. 1989. Identification of human papillomavirus type 18 transforming genes in immortalized and primary cells. J. Virol. 63:1247-1255.
9. Chen, J. J., C. E. Reid, V. Band, and E. J. Andropy. 1995. Interaction of papillomavirus E6 oncoprotein with a putative calcium-binding protein Science 269:529-531.
10. Conrad, M., V. J. Bubb, and R. Schlegel. 1993. The human papillomavirus type 6 and 16 E5 proteins arc membrane-associated proteins which associate with the 16-kilodalton pore-forming protein J. Virol. 67:6170-6178.
11. Crook, T., J. A. Tidy, and K. H. Vousden. 1991. Degradation of p53 can be targeted by HPV E6 sequences distinct from those required for p53 binding and trans-activation. Cell 67:547-556.
12. Crook, T., D. Wrede, and K. H. Vousden. 1991. p53 point mutation in HPV negative human cervical carcinoma cell lines. Oncogene 6:873-875.
13. Desaintes, C., S. Hallez, P. Van Alphen, and A. Burny. 1992. Transcriptional activation of several heterologous promoters by the E6 protein of human papillomavirus type 16. J. Virol. 66:325-333.
14. Dingwell, C., and R. A. Laskey. 1991. Nuclear targeting sequences a consensus? Trends Biochem. Sci. 16:478-481.
15. Dingwell, C., J. Robbines, S. M. Dilworth, B. Roberts, and W. D. Richardson. 1988. The nucleoplasmin nuclear location sequence is larger and more complex than that of SV-40 large T antigen. J. Cell Biol. 107:841-849.
16. Doorbar, J., A. Parton, K. Hartley, L. Banks, T. Crook, M. Stanley, and L. Crawford. 1990. Detection of novel splicing patterns in a HPV 16 containing keratinocyte cell lines Virology 178:254-262.
17. Dyson, N., P. M. Howley, K. Munger, and E. Harlow, 1989. The human papillomavirus 16 E7 oncoprotein is able to bind the retinoblastoma gene product. Science 243:934-937.
18. Garcia-Bustos, J., J. Heitman, and M. N. Hall. 1991. Nuclear protein localization, Biochim. Biophys Acta 107:83-101.
19. Halbert, C. L., B. W. Deniers, and D. A. Galloway. 1991. The E7 gene of human papillomavirus type 16 is sufficient for immortalization of human epithelial cells. J. Virol. 65:473-478.
20. Halbert, C. L., G. W. Demers, and D. A. Galloway. 1992. The E6 and E7 genes of human papillomavirus type 6 have weak immortalizing activity in human epithelial cells. J. Virol 66:2125-2134.
21. Hawley-Nelson, P., K. H. Vousden, N. L. Hubbert, D. R. Lowy, and J. T. Schiller. 1989. HPV-16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes, EMBO J 8:3905-3910.
22. Hennings, H., K. A. Holbrook, and S. H. Yuspa. 1983. Factors influencing calcium-induced terminal differentiation in cultured mouse epidermal cells. J. Cell Physiol. 116:265-281
23. Hennings, H., D. Michael, C. Cheng, P. Steinert, K. Holbrook, and S. H. Yuspa. 1980. Calcium regulation of growth and differentiation of mouse epidermal cells in culture. Cell 19:245-254.
24. Hubbert, N. L., S. A. Sedman, and J. T. Schiller. 1992. Human papillomavirus type 16 E6 increases the degradation rate of p53 in human keratinocytes. J. Virol 66:6237-6241.
25. Hudson, J. B., M. A. Bedell, D. J. McCance, and L. A. Laimins. 1990. Immortalization and altered differentiation of human keratinocytes in vitro by the E6 and E7 open reading frames of human papillomavirus type 18. J. Virol. 64:519-526.
26. Huibregtse, J. M., M. Scheffner, and P. M. Howley. 1991. A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18 EMBO J. 10:4129-4135.
27. Kalderon, D., B. L. Roberts, W. D. Richardson, and A. E. Smith. 1984. A short amino acid sequence able to specify nuclear location. Cell 39:499-509.
28. Kanda, T., A. Furuno, and K. Voshiike. 1988 Human papiltomavirus type 16 open reading frame E7 encodes a transforming gene for rat 3Y1 cells. J. Virol. 62:610-613.
29. Kanda, T., S. Watanabe, S. Zanma, H. Sato, A. Furuno, and K. Yoshiike. 1991. Human papillomavirus type 16 E6 protein with glycine substitution for cysteine in the metal-binding motif. Virology 185:536-548.
30. Keen, N., R. Elston, and L. Crawford. 1994. Interaction of the E6 protein of human papillomavirus with cellular proteins. Oncoprotein 9:1493-1499.
31. Kozak, M. 1987. At least six nucleotides preceding the AUG initiatior codon enhance translation in mammalian cells. J Mol. Biol. 196:947-950.
32. Kulesz-Martin, M. F., B. Kochler, H. Hennings, and S. H. Yuspa. 1980. Quantitative assay for carcinogen altered differentiation in mouse epidermal cells. Carcinogenesis 1:995-1006.
33. Lechner, M. S., D. H. Mack, A. B. Finicle, T. Crook, K. H. Vousden, and L. A. Laimins. 1992. Human papillomavirus E6 proteins bind p53 in vivo and abrogate p53 mediated repression of transactivation EMBO J. 11:3045-30527.
34. Liang, X. H., M. Volkmann, R. Klein, B. Herman, and S. J. Lockett. 1993. Co-localization of the tumor suppressor protein p53 and human papillomavirus E6 protein in human cervical carcinoma cell lines. Oncogene 8:2645-2652.
35. Lim, P. S., A. B. Jenson, L. Cowsert, Y. Nakai, L. Y. Lim, X. W. Jin, and J. P. Sundberg. 1990. Distribution and specific identification of papillomavirus major capsid protein epitopes by immunocytochemistry and epitope scanning of synthetic peptides. J. Infect. Dis 162:1263-1269.
36. Liu, A., J. Ghai, R. S. Ostrow, R. C. McGlennen, and A. J. Faras. 1994. The E6 gene of human papillomavirus type 16 is sufficient for transformation of baby rat kidney cells in cotranstection with activated Ha-ras. Virology 201: 388-396.
37. Malion, R. G., D. Wojciechowicz, and V. Defendi. 1987. DNA binding activity of papillomavirus proteins. J. Virol. 61:1655-1660.
38. McCall, C. A., and J. J. Cohen. 1991. Programmed cell death in terminally differentiating keratinocytes. role of endogenous endonuclease. J. Invest. Dermatol. 97:111-114.
39. Momand, J., G. P. Zambetti, D. C. Olson, D. George, and A. J. Levine. 1992. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53 mediated transactivation. Cell 69:1237-1245
40. Munger, K., W. C. Phelps, V. Bubb, P. M. Howley, and R. Schlegel. 1989. The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes. J. Virol. 63:4417-4421.
41. Munger, K., B. A. Werness, N. Dyson, W. C. Phelps, and P. M. Howley. 1989. Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product EMBO J. 8:4099-4-105.
42. Pan, H., and A. E. Griep. 1994. Altered cell cycle regulation in the lens of the HPV 16 E6 or E7 transgenic mice: implications for tumor suppressor gene function in development. Genes Dev. 8:1285-1299.
43. Phelps, W. C., C. L. Yee, K. Munger, and P. M. Howley. 1988. The human papillomavirus type 16 E7 gene encodes transactivation and transformation functions similar to those of adenovirus E1A. Cell 53:539-547.
44. Scheffner, M., K. Munger, J. C. Byrne, and P. M. Howley. 1991. The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines. Proc. Natl. Acad. Sci. USA 88:5523-5527.
45. Scheffner, M., B. A. Werness, J. M. Huibregtse, A. J. Levine, and P. M. Howley. 1990 The E6 oncoprotein encoded by human papillomavirus type 16 and 18 promotes the degradation of p53. Cell 63:1129-1136.
46. Schlegel, R., W. C. Phelps, Y.-L. Zhang, and M. Barbosa. 1988. Quantitative keratinocyte assay detects two biological activities of human papillomavirus DNA and identifies viral types associated with cervical carcinoma. EMBO J. 7:3181-3187.
47. Schneider-Gadicke, A., S. Kaul, E. Schwarz, H. Gausepohl, R. Frank, and G. Bastert. 1988. Identification of the human papillomavirus type 18 E6* and E6 proteins in nuclear protein fractions from human cervical carcinoma cells grown in the nude mouse or in-vitro. Cancer Res. 48:2969-2974.
48. Schneider-Gadicke, A., and E. Schwarz. 1986. Different human cervical carcinoma cell lines show similar transcription patterns of human papillomavirus type 18 early genes. EMBO J. 5:2285-2292.
49. Schwarz, E., U. K. Freese, L. Gissman, W. Mayer, B. Roggenback, A. Stremlau, and H. zur Hausen. 1985. Structure and transcription of human papilloraavirus virus sequences in cervical carcinoma cells. Nature (London) 314: 111-114
50. Sedman, S. A., M. S. Barbosa, W. C. Vass, N. L. Hubbert, J. A. Haas, D. R. Lowy, and J. T. Schiller. 1991. The full-length human herpesvirus E6 protein has transforming and transactivating activities and cooperates with E7 to immortalize keratinocytes in culture. J. Virol. 65:4860-4866.
51. Sedman, S. A., N. L. Habbert, W. C. Vass, D. R. Lowy, and J. T. Schiller. 1992. Mutant p53 can substitute for human papillomavirus type 16 E6 in immortalization of human keratinocytes but does not have E6-associated transactivation or transforming activity. J. Virol 66:4201-4208.
52. Seedorf, K., G. Krammer, M. Durst, S. Suhai, and W. G. Rowekamp. 1985. Human papillomavinis type 16 DNA sequence. Virology 145:181-185.
53. Seedorf, K., T. Oltersdorf, G. Krammer, and W. Rowekamp. 1987. Identifi-cation of early proteins of the human papillomaviruses type 16 (HPV16) and type 18 (HPV18) in cervical carcinoma cells. EMBO J. 6:139-144.
54. Shally, M., N. Alloul, M. Muller, L. Gissman, and L. Sherman. Submitted for publication.
55. Sherman, L., and N. Alloul. 1992. Human papillomavirus type 16 expresses a variety of alternatively spliced mRNAs putatively encoding the E2 protein. Virology 191:953-959
56. Smotkin, D., H. Prokoph, and F. O. Wettstein. 1989. Oncogenic and non-oncogenic human genital papillomaviruses generate the E7 mRNA by different mechanisms. J. Virol. 63:1441-1447.
57. Smotkin, D., and F. O. Wettstein. 1986. Transcription of human papillomavirus type 16 early genes in a cervical cancer and cancer-derived cell line and identification of the E7 protein. Proc. Natl. Acad. Sci. USA 83:4680-4684.
58. Sparkowski, J., J. Anders, and R. Schlegel. 1994. Mutation of the bovine papillomavirus E5 oncoprotein at amino acid 17 generates both high- and low-transforming variants J. Virol. 68:6120-6123.
59. Storey, A., and L. Banks. 1993. Human papillomavirus type 16 E6 gene cooperates with EJ-ras to immortalize primary mouse cells. Oncogene 8: 919-924.
60. Underwood, M. R., and H. M. Fried. 1990 Characterization of nuclear localization sequences from yeast ribosomal protein L29. EMBO J. 9:91-99.
61. Villa, L. L., and R. Schlegel. 1991. Differences in transformation activity between HPV18 and HPV16 map to the viral LCR E6-E7 region. Virology 181:374-377.
62. Voiz, A., B. P. Korge, J. G. Compton, A. Ziegler, P. M. Steinert, and D. Mischke. 1993. Physical mapping of a functional cluster of epidermal differentiation genes on chromosome Iq21. Genomics 18:92-99.
63. Vousden, K. H., J. Doniger, J. A. DiPaolo, and D. R. Lowy. 1988. The E7 open reading frame of human papillomavirus type 16 encodes a transforming gene. Oncogene Res. 3:167-175.
64. Werness, B. A., A. J. Levine, and P. M. Howley. 1990. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 248:76-79.
65. Wilson, I. A., H. L. Niman, R. A. Houghten, A. R. Cherenson, M. L. Connolly, and R. A. Lerner. 1984. The structure of an antigenic determinant in a protein. Cell 37:767-778.
66. Woodworth, C. D., S. Cheng, S. Simpson, L. Hamacher, L. T. Chow, T. R. Broker, and J. A. DiPaolo. 1992. Recombinant retroviruses encoding human papilloavirus type 18 E6 and E7 stimulate proliferation and delay differentiation of human keratinocytes early after infection. Oncogene 7:619-626.
67. Yuspa, S. H., and D. L. Morgan. 1981. Mouse skin cells resistant to terminal differentiation associated with initiation of carcinogenesis. Nature (London) 293:72-74
68. zur Hausen, H. 1989. Papillomaviruses as carcinomaviruses. Adv. Viral Oncol. 8:1-26